Chevy Chase Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Chevy Chase Trust Holdings, Inc.

$30.3 Billion
Q1 2024

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 242,380 shares of REGN stock, worth $238 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

242,380

Previous 249,577 2.88%

Holding current value

$238 Million

Previous $219 Million 6.43%

% of portfolio

0.77%

Previous 0.79%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$902.69 - $993.35 $6.5 Million - $7.15 Million	-7,197 Reduced 2.88%	242,380 $233 Million
Q4 2023 Jan 24, 2024	SELL	$775.18 - $881.7 $1.04 Million - $1.19 Million	-1,344 Reduced 0.54%	249,577 $219 Million
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $1.25 Million - $1.53 Million	-1,811 Reduced 0.72%	250,921 $206 Million
Q2 2023 Jul 25, 2023	SELL	$700.03 - $830.35 $1.22 Million - $1.44 Million	-1,736 Reduced 0.68%	252,732 $182 Million
Q1 2023 May 17, 2023	BUY	$680.49 - $826.97 $172 Million - $209 Million	252,546 Added 13139.75%	254,468 $209 Million

Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $174 Million - $212 Million	-256,212 Reduced 99.26%	1,922 $1.58 Billion
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $15.7 Million - $17 Million	-22,210 Reduced 7.92%	258,134 $186 Million
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $8.54 Million - $10.8 Million	14,881 Added 5.61%	280,344 $193 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $8.46 Million - $11.4 Million	15,428 Added 6.17%	265,463 $157 Million
Q1 2022 Apr 27, 2022	BUY	$595.12 - $698.43 $10.8 Million - $12.7 Million	18,161 Added 7.83%	250,035 $175 Million
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $5.77 Million - $7.12 Million	10,618 Added 4.8%	231,874 $146 Million
Q3 2021 Oct 20, 2021	BUY	$574.03 - $680.96 $23.1 Million - $27.4 Million	40,261 Added 22.24%	221,256 $134 Million
Q2 2021 Jul 20, 2021	BUY	$472.8 - $558.54 $5.51 Million - $6.51 Million	11,658 Added 6.88%	180,995 $101 Million
Q1 2021 Apr 22, 2021	BUY	$446.73 - $548.2 $14.4 Million - $17.7 Million	32,207 Added 23.49%	169,337 $80.1 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $2.35 Million - $2.99 Million	-4,915 Reduced 3.46%	137,130 $66.3 Million
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $4.72 Million - $5.7 Million	8,664 Added 6.5%	142,045 $79.5 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $23.7 Million - $30.9 Million	47,978 Added 56.18%	133,381 $83.2 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $373,159 - $548,817	1,110 Added 1.32%	85,403 $41.7 Million
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $861,316 - $1.18 Million	-3,142 Reduced 3.59%	84,293 $31.7 Million
Q3 2019 Nov 20, 2019	SELL	$273.46 - $318.39 $10.2 Million - $11.8 Million	-37,187 Reduced 29.84%	87,435 $24.3 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $7.22 Million - $10 Million	-24,106 Reduced 16.21%	124,622 $39 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $10.8 Million - $12.8 Million	29,030 Added 24.25%	148,728 $51.6 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $4.45 Million - $5.34 Million	13,242 Added 12.44%	119,698 $44.7 Million
Q3 2018 Oct 23, 2018	BUY	$351.14 - $408.51 $1.62 Million - $1.88 Million	4,600 Added 4.52%	106,456 $43 Million
Q2 2018 Aug 02, 2018	BUY	$284.6 - $344.99 $731,706 - $886,969	2,571 Added 2.59%	101,856 $35.1 Million
Q1 2018 Apr 10, 2018	SELL	$315.82 - $393.78 $1.05 Million - $1.31 Million	-3,338 Reduced 3.25%	99,285 $34.2 Million
Q4 2017 Jan 22, 2018	SELL	$358.63 - $469.95 $9.65 Million - $12.6 Million	-26,896 Reduced 20.77%	102,623 $38.6 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $55.9 Million - $65.3 Million	129,519	129,519 $57.9 Million

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $105B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Account

Chevy Chase Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History